LEO Pharma to acquire gene therapy company Replay

LEO Pharma will integrate Replay’s HSV gene therapy design and manufacturing specialists into its dermatology portfolio. Credit: Gorodenkoff / Shutterstock.com.



  • LEO Pharma Replay